ToxSci Advance Access published online on August 3, 2007
Toxicological Sciences, doi:10.1093/toxsci/kfm177
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Dynamic epigenome and its implications in toxicology
1 Department of Pharmacology and Therapeutics, McGill University, 3655 Sir William Osler Promenade, Montréal, Québec H3G 1Y6, Canada
* To whom correspondence should be addressed at moshe.szyf{at}mcgill.ca
Received May 6, 2007; revision received June 7, 2007; accepted July 6, 2007
 |
Abstract |
|---|
The epigenome serves as an interface between the dynamic environment and the inherited static genome. The epigenome is comprised of chromatin and a covalent modification of DNA by methylation. The epigenome is sculpted during development to shape the diversity of gene expression programs in the different cell types of the organism by a highly organized process. Epigenetic aberrations have similar consequences to genetic polymorphisms resulting in variations in gene function. Recent data suggests that the epigenome is dynamic and is therefore responsive to environmental signals not only during the critical periods in development but also later in life as well. It is postulated here that not only chemicals but also exposure to social behavior, such as maternal care, could affect the epigenome. It is proposed that exposures to different environmental agents could lead to inter-individual phenotypic diversity as well as differential susceptibility to disease and behavioral pathologies. Inter-individual differences in the epigenetic state could also affect susceptibility to xenobiotics. Although our current understanding of how epigenetic mechanisms impact on the toxic action of xenobiotics is very limited, it is anticipated that in the future, epigenetics will be incorporated in the assessment of the safety of chemicals.